News & Resources

We invite you to visit this page often for the latest company news and resources. If you can't find what you are looking for, please Contact Us for more information. For media and analyst inquiries, please contact Kathleen Fusco at 215-939-5709 or kathleen@0to5.com.

Press Releases
10/11/2016
New TissueCypher® Validation Study identifies high risk Barrett’s Esophagus patients who are 46x more likely to have cancer at time of biopsy... Read More
08/31/2016
UPMC Partners with Cernostics to Pursue ‘Precision Medicine’... Read More
05/11/2016
Cernostics Announces Scientific Presentations at DDW and ISPOR Meetings Demonstrating Clinical Validation and Cost-Effectiveness of New TissueCypher® Barrett's Esophagus Assay... Read More
Media Coverage
Improved Testing for Barrett's Esophagus... Read More
NewCo on the Go: Cernostics aims to help GIs manage Barrett’s patients... Read More
Mike Hoerres Discusses Cernostics and Its Lead Product Under Development... Read More
Publications
2016 / Medical Laboratory Observer
Individualized risk prediction in Barrett’s esophagus
Barrett’s esophagus (BE), which is a precursor to esophageal adenocarcinoma (EAC), is an increasing healthcare challenge in the United States, but new tools are quickly emerging to combat the uncertainty associated with the disease. Barrett’s esophagus management decisions are often based on sub... Read More
2010 / Springer
Immune Signatures Associated with the Cancer Bearing State
Dysfunction of the host immune system can be detected in many patients with different cancer types, and contributes to tumor escape and failure of therapies that aim to elicit or boost anti-tumor immunity. Yet, immune-mediated tumor rejection and long term cancer control have been documented in a mi... Read More
2011 / Journal of Pathology Informatics
High-throughput profiling of tissue and tissue model microarrays: Combined transmitted light and 3-color fluorescence digital pathology
For many years pathologists have used Hematoxylin and Eosin (H&E), single marker immunohistochemistry (IHC) and in situ hybridization with manual analysis by microscopy or at best simple digital imaging. There is a growing trend to update pathology... Read More
Customer Service

Mon-Fri 9am-5pm (EST)

×